ADAMTS expression in colorectal cancer

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Filou, Serafula ^a   Korpetinou, Aggeliki ^a   Kyriakopoulou, Dora ^b   Bounias, Dimitrios ^b   Stavropoulos, Michael ^b   Ravazoula, Panagiota ^b   Papachristou, Dionysios J ^a   Theocharis, Achilleas D ^a   Vynios, Demitrios H ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS PROTEIN; ADAMTS1 PROTEIN; ADAMTS20 PROTEIN; AGGRECANASE 1; AGGRECANASE 2; MESSENGER RNA; METALLOPROTEINASE; UNCLASSIFIED DRUG; ADAM PROTEIN; ANGIOGENESIS INHIBITOR;

ADULT; AGED; ARTICLE; CACO 2 CELL LINE; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DLD 1 CELL LINE; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HT 29 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; COLORECTAL NEOPLASMS; DRUG DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION; VERY ELDERLY;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG DISCOVERY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS;

EID: 84925424724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121209     Document Type: Article

References (36)

1. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer. 2014; 120: 1290-1314. doi: 10.1002/cncr.28509 PMID: 24343171
2. Center MM, Jemal A, Ward E. International Trends in Colorectal Cancer. Incidence Rates. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1688-1694. doi: 10.1158/1055-9965.EPI-09-0090 PMID: 19505900
3. Van der Jagt MF, Wobbes T, Strobbe LJ, Sweep FC, Span PN. Metalloproteinases and their regulators in colorectal cancer. J Surg Oncol. 2010; 101: 259-269. doi: 10.1002/jso.21462 PMID: 20039272
4. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al. Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family. J Biol Chem. 1999; 274: 23443-23450. PMID: 10438522
5. Apte S. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol. 2004; 36: 981-985. PMID: 15094112
6. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene. 2002; 283: 49-62. PMID: 11867212
7. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J. 2005; 386: 15-27. PMID: 15554875
8. Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, et al. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J Biol Chem. 2000; 275: 22695-22703. PMID: 10801887
9. Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol. 2004; 23: 219-230. PMID: 15296936
10. Vázquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem. 1999; 274: 23349-23357. PMID: 10438512
11. Lawler J. The functions of thrombospondin-1 and -2. Curr Opin Cell Biol. 2000; 12: 634-640. PMID: 10978901
12. Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, et al. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol. 2006; 28: 259-272. PMID: 17167179
13. Fernandes RJ, Hirohata S, Engle JM, Colige A, Cohn DH, Eyre DR, et al. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem. 2001; 276: 31502-31509. PMID: 11408482
14. Liu YJ, Xu Y, Yu Q. Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively. Oncogene. 2006; 25: 2452-2467. PMID: 16314835
15. Choi GC, Li J, Wang Y, Li L, Zhong L, Ma B, et al. The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. Mol Cancer Res. 2014; 12: 228-238. doi: 10.1158/1541-7786.MCR-13-0195 PMID: 24184540
16. Pedeutour F, Merscher S, Durieux E, Montgomery K, Krauter K, Clevy JP, et al. Mapping of the 12q12- q22 region with respect to tumor translocation breakpoints. Genomics. 1994; 22: 512-518. PMID: 8001964
17. Hough RE, Goepel JR, Alcock HE, Hancock BW, Lorigan PC, Hammond DW. Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer. 2001; 84: 499-503. PMID: 11207045
18. Dal Cin P, Van den Berghe H, Van Poppel H, Roskams T. Involvement of 12q12-13 is a nonrandom chromosome change in renal oncocytoma. Genes Chromosomes Cancer. 1999; 24: 94. PMID: 9892115
19. El-Rifai W, Rutherford S, Knuutila S, Frierson HF, Moskaluk CA. Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia. 2001; 3: 173-178. PMID: 11494110
20. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol. 2002; 51: 296-301. PMID: 11891824
21. Rocks N, Paulissen G, Quesada Calvo F, Polette M, Gueders M, Munaut C, et al. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer. 2006; 94: 724-730. PMID: 16495931
22. Cross NA, Chandrasekharan S, Jokonya N, Fowles A, Hamdy FC, Buttle DJ, et al. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate. 2005; 63: 269-275. PMID: 15599946
23. Przemyslaw L, Boguslaw HA, Elzbieta S, Malgorzata SM. ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis. BMB Rep. 2013; 46: 139-150. PMID: 23527857
24. Nakada M, Miyamori H, Kita D, Takahashi T, Yamashita J, Sato H, et al. Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol. 2005; 110: 239-246. PMID: 16133547
25. Held-Feindt J, Paredes EB, Blömer U, Seidenbecher C, Stark AM, Mehdorn HM, et al. Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer. 2006; 118: 55-61. PMID: 16003758
26. Mukaratirwa S, van Ederen AM, Gruys E, Nederbragt H. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumor invasion. J. Comp Pathol. 2004; 131: 259-270. PMID: 15511534
27. Skandalis SS, Labropoulou VT, Ravazoula P, Likaki-Karatza E, Dobra K, Kalofonos HP, et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer. 2011; 11: 314. doi: 10.1186/1471-2407-11-314 PMID: 21791066
28. Skandalis SS, Theocharis AD, Papageorgakopoulou N, Vynios DH, Theocharis DA. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie. 2006; 88: 1135-1143. PMID: 16690200
29. Filou S, Stylianou M, Triantaphyllidou IE, Papadas T, Mastronikolis NS, Goumas PD, et al. Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma. Biochimie. 2013; 95: 725-734. doi: 10.1016/j.biochi.2012.10.022 PMID: 23131589
30. Tsara ME, Theocharis AD, Theocharis DA. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res. 2002; 22: 2893-2898. PMID: 12530013
31. Zeng W, Corcoran C, Collins-Racie LA, LaVallie ER, Morris EA, Flannery CR. Glycosaminoglycanbinding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18. Biochim Biophys Acta. 2006; 1760: 517-524. PMID: 16507336
32. Thirunavukkarasu K, Pei Y, Moore TL, Wang H, Yu XP, Geiser AG, et al. Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. Biochem Biophys Res Commun. 2006; 345: 197-204. PMID: 16677612
33. Sawaji Y, Hynes J, Vincent T, Saklatvala J. Fibroblast Growth Factor 2 Inhibits Induction of Aggrecanase Activity in Human Articular Cartilage. Arthitis Rheum. 2008; 58: 3498-3509. doi: 10.1002/art.24025 PMID: 18975307
34. Bouga H, Kyriakopoulou D, Stavropoulos M, Papageorgakopoulou N, Theocharis DA, Vynios DH. Involvement of hyaluronidases in colorectal cancer. BMC Cancer. 2010; 10: 499. doi: 10.1186/1471-2407-10-499 PMID: 20849597
35. Rao N, Ke Z, Liu H, Ho CJ, Kumar S, Xiang W, et al. ADAMTS4 and its proteolytic fragments differentially affect melanoma growth and angiogenesis in mice. Int J Cancer. 2013; 133: 294-306. doi: 10.1002/ijc.28037 PMID: 23319426
36. Rodriguez-Manzaneque JC, Milchanowski BA, Dufour EK, Leduc R, Iruela-Arispe L. Characterization of METH-1/ADAMTS1 Processing Reveals Two Distinct Active Forms. J Biol Chem. 2000; 275: 33471-33479. PMID: 10944521